ABXL vs MCK · rev $235.2M vs P/E 20, rev $403.43B
ABXL (ABXL) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
ABXL (ABXL) common stock listed on NYSE.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported ABXL revenue for 2025-12-31 was $235.2M. Net income was $36.5M. Revenue was up 110.2% from 2024-12-31 to 2025-12-31. ABXL currently screens at market cap $0.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
ABXL currently screens at market cap $0. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the ABXL and MCK stock pages for the full models.
Not investment advice.